Shenzhen New Industries Biomedical Engineering Co Ltd

CN

Health Care

64.88 ₽

Current price

Strong buy
64.88 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    28 / 236

  • Position in country

    1165 / 7387

  • Return on Assets, %

    22.1

    1.6

  • Net income margin, %

    43.7

    2.7

  • EBITDA margin, %

    52.3

    10.2

  • Debt to Equity, %

    0

    13.9

  • Intangible assets and goodwill, %

    2

    2.7

  • Revenue CAGR 3Y, %

    21.4

    11.3

  • Total Equity change 1Y, %

    14.5

    -0.3

  • Revenue Y, % chg

    22.3

    0

  • P/E

    31.2

    25.8

  • P/BV

    6.8

    1.5

  • P/S

    13.1

    2.8

  • EV/S

    12.2

    2.5

  • EV/EBITDA

    27.2

    9

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    27.7

    36.5

  • Forward P/E

    22.7

    18.3

  • Dividend Yield, %

    1

    2

  • Forward Dividend Yield, %

    0.2

    0.2

  • Expected dividend per share

    0.1

    0

  • Payout Ratio, %

    47.5

    32.2

Get an analytical review of this company

Competitors

Ranks

  • Shanghai MicroPort Endovascular MedTech Group Co Ltd

    00%

  • Shenzhen New Industries Biomedical Engineering Co Ltd

    00%

  • Winner Medical Co Ltd

    00%

  • Micro-Tech Nanjing Co Ltd

    00%

  • Autek China Inc

    00%

  • Autobio Diagnostics Co Ltd

    00%

  • Eyebright Medical Technology Beijing Co Ltd

    00%

  • Shandong Weigao Group Medical Polymer Co Ltd

    00%

  • Shandong Pharmaceutical Glass Co Ltd

    00%

  • Intco Medical Technology Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    7144.6

  • Ticker

    300832.SZ

  • ISIN

    CNE100003T39

  • IPO date

    2020-05-12

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-04-11

  • Date fact. publication of reports

    2023-12-31

Company Description

Shenzhen New Industries Biomedical Engineering Co Ltd is a company engaged in research and development, production and sales of in-vitro diagnostics instruments and supporting reagents. The Company operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic chemiluminescence immunoassay analyzer series products and Biossays automatic biochemical analyzer series products. Reagents segment operates the sales of supporting reagents for the analyzers. The products are applied in the examination of Gonads, thyroid gland, glucose metabolism, kidney function and so on. Accessories and Others segment is responsible for the manufacturing and sales of accessories related to in-vitro diagnostics equipment. The Company sells its products both in domestic and international markets, including Asia, Europe, America and Africa.